Steward Partners Investment Advisory, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$5,142
-11.1%
189
+0.5%
0.00%
Q2 2023$5,783
-24.3%
188
-11.3%
0.00%
Q1 2023$7,638
+1.3%
212
+11.0%
0.00%
Q4 2022$7,543
+7.8%
191
+3.2%
0.00%
Q3 2022$7,000
-12.5%
1850.0%0.00%
Q2 2022$8,000
+14.3%
1850.0%0.00%
Q1 2022$7,0000.0%1850.0%0.00%
Q4 2021$7,0001850.00%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders